KIORA PHARMACEUTICALS, INC. Revenue Breakdown
No Revenue Breakdown for KPRX on this site yet.
- 2025-12-31: Total revenue $0.00.
- 2024-12-31: Others Not split by product in the filing$16.02M100.00%; Total revenue $16.02M.
- 2023-12-31: Total revenue $0.00.
- 2021-12-31: Total revenue $0.00.
Source checked: the stored Revenue Breakdown page for KPRX.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | $0.00 | |
| 2024-12-31 | Not split by product in the filing $16.02M 100.00% | $16.02M |
| 2023-12-31 | $0.00 | |
| 2021-12-31 | $0.00 | |
| 2020-12-31 | $12.06K | |
| 2019-12-31 | Not split by product in the filing $2.69M 100.00% | $2.69M |
| 2018-12-31 | Not split by product in the filing $1.65M 100.00% | $1.65M |
| 2017-12-31 | $407.52K | |
| 2016-12-31 | Not split by product in the filing $669.26K 100.00% | $669.26K |
| 2015-12-31 | $0.00 |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product $0.00 | $0.00 |
| 2025-09-30 | Not split by product $0.00 | $0.00 |
| 2025-06-30 | Not split by product $0.00 | $0.00 |
| 2025-03-31 | Not split by product $0.00 | $0.00 |
| 2024-12-31 | Not split by product $0.00 | $0.00 |
| 2024-09-30 | Not split by product $0.00 | $0.00 |
| 2024-06-30 | Not split by product $20.00K 100.00% | $20.00K |
| 2024-03-31 | Not split by product $16.00M 100.00% | $16.00M |
| 2023-12-31 | Not split by product $0.00 | $0.00 |
| 2023-09-30 | Not split by product $0.00 | $0.00 |
| 2023-06-30 | Not split by product $0.00 | $0.00 |
| 2023-03-31 | Not split by product $0.00 | $0.00 |
| 2020-12-31 | Not split by product $12.06K 100.00% | $12.06K |
| 2020-09-30 | Not split by product $0.00 | $0.00 |
| 2020-06-30 | Not split by product $0.00 | $0.00 |
| 2020-03-31 | Not split by product $0.00 | $0.00 |
| 2019-12-31 | Not split by product $0.00 | $0.00 |
| 2019-09-30 | Not split by product $0.00 | $0.00 |
| 2019-06-30 | Not split by product $0.00 | $0.00 |
| 2019-03-31 | Not split by product $2.69M 100.00% | $2.69M |
| 2018-12-31 | Not split by product $0.00 | $0.00 |
| 2018-09-30 | Not split by product $314.50K 100.00% | $314.50K |
| 2018-06-30 | Not split by product $242.01K 100.00% | $242.01K |
| 2018-03-31 | Not split by product $1.10M 100.00% | $1.10M |
| 2017-12-31 | Not split by product $0.00 | $0.00 |
| 2017-09-30 | Not split by product $74.70K 100.00% | $74.70K |
| 2017-06-30 | Not split by product $148.29K 100.00% | $148.29K |
| 2017-03-31 | Not split by product $184.53K 100.00% | $184.53K |
| 2016-12-31 | Not split by product $160.37K 100.00% | $160.37K |
| 2016-09-30 | Not split by product $274.29K 100.00% | $274.29K |
| 2016-06-30 | Not split by product $234.60K 100.00% | $234.60K |
| 2016-03-31 | Not split by product $0.00 | $0.00 |
| 2015-12-31 | Not split by product $0.00 | $0.00 |
| 2015-09-30 | Not split by product $0.00 | $0.00 |
| 2015-06-30 | Not split by product $0.00 | $0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |